Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents

Clinical trial NCT01721109 · COMPLETED

Trial details

NCT number: NCT01721109
Sponsor: Gilead Sciences
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Acquired Immunodeficiency Syndrome HIV Infections

Start date: 2012-12-06
Primary completion: 2015-10-22
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.